NPPA and congestive heart failure: The results showed that SFAS-H could increase LVEF and LVFS, improve hypertrophy and necrosis of cardiomyocytes and myocardial fibrosis, and reduce cardiac ANP, BNP, NE, and MDA levels in CHF rats.